Life Science Nation (LSN)

What Life Science Nation (LSN) does

Life Science Nation (LSN) is a private, founder-led global partnering ecosystem company headquartered in Cambridge, MA, that connects early-stage life science companies across Drugs, Devices, Diagnostics, and Digital Health ("the 4 Ds") with cross-border investors and licensing partners. Founded in 2012 by Dennis Ford, LSN operates three integrated product lines: the Global Partnering Campaign — a Salesforce.com-integrated capital formation platform powered by Biotechgate that combines a curated database of 4,000+ verified investor and licensing partner profiles with a business development database to support 9–18 month CRM-driven outreach campaigns targeting 600–800 qualified investors; the RESI (Redefining Early Stage Investments) Conference Series, a partnering marketplace running five events annually across the US, Europe, and Asia Pacific; and LSN Labs, an education and readiness program including an AI-powered messaging assessment tool (LSN BD Assist) and the Anchor Node de-risking framework. Adjacent offerings include the Focus on Cures Accelerator, a 45,000-readership Next Phase Newsletter, the Fundraising Manifesto book, and the Science to Signal publication series.

LSN's commercial model is sales-led and event-driven, with quote-based pricing across subscriptions (RESI registration, database access) and professional services (campaign execution, LSN Labs programs). Distribution combines direct sales via a small business development team with a regional partner network (accelerators, universities, tech hubs) that funnels early-stage companies into LSN's campaign pipeline. Customer evidence cited by the company includes 400+ companies having raised more than $5B through LSN services over the past decade, with 90+ companies directly attributing $1.3B to LSN-supported campaigns, and a single Brisbane cohort of 30 companies reporting $240M raised across three program iterations. The company is private with 11–50 employees, no disclosed institutional funding, and reported operations across North America, EMEA (UK, Portugal), Asia-Pacific (Singapore, China, Australia), and LATAM (Brazil).

Revenue mechanics blend recurring event registrations, multi-year database subscriptions, and project-based professional services contracts. The platform targets four primary stakeholder groups: early-stage life science companies seeking capital, capital investors and licensing partners sourcing deal flow, regional governments and tech hubs building innovation capacity, and the broader innovation ecosystem (universities, hospitals, research institutions) needing commercial translation support. LSN's geographic footprint is delivered through physical events rather than employed sales coverage, with operational concentration in Cambridge and EMEA leadership provided by VP Greg Mannix.

Name

Life Science Nation (LSN)

Legal name

Life Science Nation

Website

https://lifesciencenation.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Life Science Nation (LSN) operates a global partnering ecosystem connecting early-stage life science companies across Drugs, Devices, Diagnostics, and Digital Health with 4,000+ verified investors and licensing partners through Salesforce-integrated campaigns, the five-times-yearly RESI Conference Series, and LSN Labs readiness programs.

Ownership category

akta.pro rank

Product category

Life Science Partnering and Capital Formation Services

NAICS

Other Scientific and Technical Consulting Services (54169), Software Publishers (5132)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Life Sciences & Biotechnology Congresses (THAHAJAB)

Keywords

• Life science partnering
• Investor matching platform
• Capital formation services
• Partnering conferences
• Investor database services

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. RESI Conference Registration: Revenue from hosting the Redefining Early Stage Investments (RESI) conference series, running 5 times annually across US, Europe, and Asia Pacific. Companies pay registration fees to participate in partnering events, investor panels, and the Innovator's Pitch Challenge. RESI Europe registration costs approximately half of many large European partnering conferences.
2. Global Partnering Campaign Services: Fee-based services providing companies with access to LSN's curated investor and licensing partner database, CRM integration, and campaign execution support for capital formation campaigns.
3. LSN Labs Programs: Entrepreneurial education and readiness programs including curriculum, workshops, and acceleration services for early-stage life science companies. Services include AI-powered messaging assessment and hands-on business development support.
4. Database Subscriptions: Access to LSN's verified investor and licensing partner database with mandate matching capabilities, integrated with Salesforce.com.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Life Science Nation operates a global partnering ecosystem for early-stage life science companies across Drugs, Devices, Diagnostics, and Digital Health. Its core offering combines a curated, verified database of more than 4,000 global investors and licensing partners with the RESI conference series (running five times per year across the US, Europe, and Asia Pacific), the Global Partnering Campaign service integrating the database with Salesforce.com for 9-18 month capital formation campaigns, and LSN Labs programs for company preparation including AI-powered messaging assessment and the Focus on Cures Accelerator.

Product overview

Life Science Nation (LSN) is a global partnering ecosystem platform for the life science industry, connecting early-stage companies with investors and channel partners across Drugs, Devices, Diagnostics, and Digital Health. The platform operates as a unified system comprising three core integrated products: (1) the Global Partnering Campaign, which combines Salesforce-integrated CRM tools with LSN's Investor Database and Business Development Database to enable structured 9-18 month capital formation campaigns targeting 600-800 qualified investors; (2) the RESI Conference Series, running five times annually across the US, Europe, and Asia Pacific as a structured partnering marketplace; and (3) LSN Labs, offering AI-powered BD Assist, entrepreneurial education, and the Anchor Node de-risking framework. Supporting offerings include the Focus on Cures Accelerator, Next Phase Newsletter (45K readership), The Life Science Executive's Fundraising Manifesto book, Science to Signal publication, and Next Phase Podcast. The platform is powered by Biotechgate technology and has facilitated over $5 billion raised by 400+ companies.

Differentiator

Problem solved

Functional benefit

Brands

• RESI Conference Series: Ongoing conference series of 5 times per year establishing a global circuit for early-stage life sciences companies to source investors, create relationships, and get funding.
• LSN Labs
• Focus on Cures Accelerator (FOC)
• LSN BD Assist
• Anchor Node Framework
• Next Phase Weekly

Products and services

• Global Partnering Campaign
• LSN Investor Database
• LSN Business Development Database
• RESI Conference Series
• LSN Labs
• Focus on Cures Accelerator (FOC)
• Entrepreneur Education Program

Quantifiable outcome

• 400+ companies raised $5B+ over the past decade
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature5 records

Partnerships

One partnership is on record.

• Dealflow.eucoreGTM or Marketing Partner · 10 February 2026Dealflow.eu, a European innovation matchmaking and readiness platform, named as Title Sponsor of RESI Europe Lisbon. Dealflow.eu routes curated cohorts of European life science companies to RESI events and supports eligible companies in accessing European Innovation Council (EIC) reimbursement mechanisms to offset RESI registration costs. The collaboration strengthens pathways for European innovators to engage global capital investors and licensing partners.

Scale indicators8 records

Expansion highlights5 records

Emerging players

• Dealroom.co: Dealroom.co is a global startup and investor database that partners with Dealflow.eu and serves the European innovation ecosystem. Its data platform overlaps with LSN's investor database functionality and regional partnering infrastructure in EMEA.
• IndieBio (SOSV): IndieBio is a biotech accelerator that runs cohort programs and provides seed funding and investor introductions to early-stage life science and biotech startups. It overlaps with the Focus on Cures Accelerator and LSN Labs cohort preparation offerings.
• StartUp Health: StartUp Health is a health-focused accelerator and investor network that supports early-stage health and life science founders with coaching, community, and investor introductions. It overlaps with LSN's early-stage life science capital formation focus, particularly in digital health.
• MassChallenge: MassChallenge is a global accelerator with strong life science and health tracks in Boston that prepares early-stage startups for investor engagement. Its HealthTech and Bio programs overlap with LSN Labs' preparation services for life science fundraising.

Broad incumbents

• Citeline (Informa Pharma Intelligence): Citeline is a leading provider of life science intelligence and data including clinical trials, deals, and company profiles. Its TrialTrove, Pharmaprojects, and Citeline products overlap with the data and analytics dimensions of LSN's investor and BD database offerings.
• Biotechnology Innovation Organization (BIO): BIO is the largest biotech industry trade association and runs the BIO International Convention, the largest global life science partnering event. It overlaps with LSN's RESI conference series in connecting early-stage life science companies with investors, but operates at broader scale across all stages and policy.
• BioCentury: BioCentury provides intelligence, analysis, and the BioCentury Investor Universe targeting life science investors and companies. Its BCIQ database and partnering intelligence overlap with LSN's investor database and content-driven go-to-market approach in serving biotech capital formation.

Direct peers

• Venture Valuation: Venture Valuation is a Swiss-based valuation and life science deal flow firm that owns Biotechgate. It is both LSN's technology partner and a partial competitor in providing life science company valuations and investor databases.
• EBD Group (Informa Connect): EBD Group operates BIO-Europe, BIO-Europe Spring, BIO Asia, and other partnering-focused events for the biotech industry using its partneringONE platform. It is the most direct competitor to LSN's RESI conference series for early-stage and mid-stage life science partnering globally.
• Biotechgate: Biotechgate is a life science deal flow database platform owned by Venture Valuation and serves as LSN's underlying technology partner powering the LSN platform. It offers similar company and investor profile data to life science dealmakers, making it both a partner and a partial competitor in the data layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LSciNation
• LinkedInlinkedin.com/company/life-science-nation

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Science Nation (LSN)